ATMW DC
Alternative Names: ATMW-DCLatest Information Update: 05 Nov 2024
Price :
$50 *
At a glance
- Originator Atomwise
- Class Anti-inflammatories; Skin disorder therapies; Small molecules
- Mechanism of Action TYK2 kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Psoriasis